ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 126 filers reported holding ANI PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,868 | +0.2% | 7,800 | -7.1% | 0.00% | 0.0% |
| Q2 2023 | $452,172 | +123.2% | 8,400 | +64.7% | 0.00% | 0.0% |
| Q1 2023 | $202,572 | -24.8% | 5,100 | -23.9% | 0.00% | 0.0% |
| Q4 2022 | $269,541 | -55.2% | 6,700 | -64.2% | 0.00% | -50.0% |
| Q3 2022 | $601,000 | -61.9% | 18,700 | -64.8% | 0.00% | -50.0% |
| Q2 2022 | $1,578,000 | -34.3% | 53,200 | -37.8% | 0.00% | -33.3% |
| Q1 2022 | $2,403,000 | -39.9% | 85,500 | -1.5% | 0.01% | -40.0% |
| Q4 2021 | $4,000,000 | +220.8% | 86,800 | +128.4% | 0.01% | +233.3% |
| Q3 2021 | $1,247,000 | -25.2% | 38,000 | -20.2% | 0.00% | -25.0% |
| Q2 2021 | $1,668,000 | -16.7% | 47,600 | -14.1% | 0.00% | -33.3% |
| Q1 2021 | $2,002,000 | +21.0% | 55,400 | -2.8% | 0.01% | +50.0% |
| Q4 2020 | $1,655,000 | +5.7% | 57,000 | +2.7% | 0.00% | 0.0% |
| Q3 2020 | $1,566,000 | +17.8% | 55,500 | +35.0% | 0.00% | 0.0% |
| Q2 2020 | $1,329,000 | – | 41,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |